Trump Slams Big Pharma In Rollout Of Drug Price Rules

Law360 (November 20, 2020, 10:48 PM EST) -- President Donald Trump on Friday announced two finalized policies aimed at fulfilling a campaign promise to cut drug prices, a move he expects will draw legal challenges from Big Pharma.

In remarks at the White House, Trump outlined the two finalized rules, which would link Medicare reimbursement for some drugs to lower prices paid in other countries, and eliminate Anti-Kickback Statute immunity for drugmaker rebates. He initially announced the "most favored nation" model and drugmaker rebate policy proposal through executive orders in July.

Trump also announced the ending of the U.S. Food and Drug Administration's Unapproved Drugs Initiative, which encouraged drugmakers...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!